laboratory biomarker analysis

PreclinicalBiologic

UUS Department of Veterans Affairs

laboratory biomarker analysis is one of 63 biologic programs targeting Lung Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Lung CancerActive, not recruiting

Hearing LossActive, not recruiting

Lung CancerPreclinical

Active, not recruiting

Hearing LossPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

686 competitors in Lung Cancer

#DrugCompanyPhaseTrials

Tecentriq

Roche

Preclinical

9 2

Vizimpro

Pfizer

Preclinical

3 3

Libtayo

Regeneron

Preclinical

3 4

Talzenna

Pfizer

Preclinical

2 5

Folvite

Xylocaine

2 7

Immunotherapy

Bristol-Myers Squibb

Preclinical

5 8

Rilotumumab

Amgen

Preclinical

2 9

Paclitaxel and Carboplatin

Bristol-Myers Squibb

Preclinical

2 10

COVID-19 Vaccine

Moderna

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hearing Loss1 trial

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Completed·UUS Department of Veterans Affairs·Phase 2/3·NCT00477607·39 enrolled

Lung Cancer1 trial

Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer

Completed·UUniversity of Minnesota··NCT01673711·350 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for laboratory biomarker analysis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — laboratory biomarker analysis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for laboratory biomarker analysis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — US Department of Veterans Affairs company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUS Department of Veterans Affairs

laboratory biomarker analysis

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hearing Loss1 trial

Lung Cancer1 trial

References

Drug Info

Quick Facts

Related News